Instrument Inactif

Communiqués Foundation Medicine Inc

Actions

US3504651007

Recherche biotechnologique et médicale

Communiqués

07/08/18	Foundation Medicine : Setting the Pace for Blood Tumor Mutational Burden	PU
06/08/18	Foundation Medicine : Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy	BU
18/07/18	Foundation Medicine : and Guardant Health Agree to Settle Patent Infringement Lawsuit	BU
03/07/18	Beyond MSI: Expanding the Reach of Immunotherapy in Colorectal Cancer	PU
20/06/18	FOUNDATION MEDICINE, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
20/06/18	WeissLaw LLP: Foundation Medicine, Inc. Acquisition May Not Be In The Best Interest of FMI Shareholders	PR
05/06/18	Foundation Medicine : to Present at Upcoming Investor Conferences	BU
01/06/18	Foundation Medicine : Quantum Leaps for Quantitative Markers	PU
29/05/18	Foundation Medicine : and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling (CGP) to Inform Personalized Approaches in Cancer Care	BU
24/05/18	Foundation Medicine : Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck	BU
21/05/18	Foundation Medicine : Receives New ADLT Status for FoundationOne CDx™ from the Centers for Medicare and Medicaid Services (CMS)	BU
02/05/18	Foundation Medicine : Announces 2018 First Quarter Results and Recent Highlights	BU
02/05/18	Foundation Medicine : Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer	BU
27/04/18	Foundation Medicine : Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China	BU
26/04/18	Foundation Medicine : New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration	BU
11/04/18	Foundation Medicine : and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies	BU
09/04/18	Cancer Treatment Centers of America : and Foundation Medicine Launch Joint Educational Campaign to Raise Consumer Awareness of Precision Medicine Approaches in Cancer Care	PR
30/03/18	Foundation Medicine : Announces Commercial Availability of FoundationOne CDx™, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagnostics	BU
19/03/18	Foundation Medicine : Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDx™ Across All Solid Tumors	BU
16/03/18	Foundation Medicine : Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx™ in Japan	BU
13/03/18	Foundation Medicine : and Guardant Health Agree to Resolve False Advertising Lawsuit	BU
08/03/18	Foundation Medicine : to Present at Cowen and Company’s 38th Annual Healthcare Conference	BU
07/03/18	Foundation Medicine : Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook	BU
13/02/18	Foundation Medicine : Announces Timing for Fourth Quarter and Year-End 2017 Financial Results and Conference Call	BU
30/01/18	Foundation Medicine : and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clinical Trial Enrollment	BU